The Current Status of Thrombolytic Therapy

This publication has 19 references indexed in Scilit:

• Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients
  Published by Elsevier ,1994
• Individual risk assessment for intracranial haemorrhage during thrombolytic therapy
  The Lancet, 1993
• The Effects of Tissue Plasminogen Activator, Streptokinase, or Both on Coronary-Artery Patency, Ventricular Function, and Survival after Acute Myocardial Infarction
  New England Journal of Medicine, 1993
• An International Randomized Trial Comparing Four Thrombolytic Strategies for Acute Myocardial Infarction
  New England Journal of Medicine, 1993
• Late Assessment of Thrombolytic Efficacy (LATE) study with alteplase 6-24 hours after onset of acute myocardial infarction
  The Lancet, 1993
• A Comparison of Immediate Angioplasty with Thrombolytic Therapy for Acute Myocardial Infarction
  New England Journal of Medicine, 1993
• ISIS-3: a randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41 299 cases of suspected acute myocardial infarction
  Published by Elsevier ,1992
• Basic and clinical aspects of fibrinolysis and thrombolysis
  Blood, 1991
• In-hospital mortality and clinical course of 20 891 patients with suspected acute myocardial infarction randomised between alteplase and streptokinase with or without heparin
  The Lancet, 1990
• Die Kurzzeitfibrinolyse beim akuten Myokardinfarkt
  Deutsche Medizinische Wochenschrift (1946), 1973